Previous studies have suggested that the activation of NMO pathogenic B cells occurs before CD19+ B cells, and it might be more accurate to monitor CD27+/CD20+ or class-switched memory B cells in subsequent studies (8, 33, 34). The gene discussed is CD19; the disease is neuromyelitis optica.